Clinical Trial: A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763652) titled 'A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors' on Aug. 10.

Brief Summary: This is an open-label, multicenter, non-randomized Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of BL-ARC002 Injection in patients with locally advanced or metastatic solid tumors.

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Gastrointestinal Tumors Solid Tumors

Intervention: DRUG: BL-ARC002

Administration by intravenous infusion for a cycle of 6 weeks.

Recruitment Status: NOT_YET_RECRUITIN...